Antianginal means 'Trimetazidine'. Instructions for use

The drug "Trimetazidine" is considered quite effective. This is indicated by the reviews of many patients. Often, the drug "Trimetazidine" is prescribed for heart disease. His analogs include such medications as "Angiozil", "Deprenorm", Carditrim "and others.

The antianginal "Trimetazidine" (instruction for use points to this) provides myocardial cells with permanent protection against ischemia. The medication is available in the form of slow release tablets. The active substance of the drug is trimetazadine.

The drug has an antihypoxic effect.

The agent ensures the normalization of the energy metabolism of cells that have undergone ischemia or hypoxia, prevents a decrease in the content of ATP.

Taking medication "Trimetazidine" in angina reduces the frequency of attacks, increases the tolerance of physical exertion. The drug reduces the need for nitrates. In the course of the study, it was found that the use of the drug "Trimetazidine" promotes an increase in the coronary reserve, thus slowing the development of ischemia, provoked by physical stress. A persistent effect is noted from the fifteenth day of therapy. The drug "Trimetazidine" (instructions for use contains such information) is able to limit sudden changes in blood pressure without significant changes in heart rate.

With chorioretinal ischemia, the drug helps restore the retina. The drug showed its effectiveness and with reduced acuity of hearing, vestibular disorders, Meniere's disease.

The active substance is well absorbed from the digestive tract. Excretion is carried out quickly enough, mainly with urine.

"Trimetazidine" is recommended for long-term therapy of ischemic heart disease as a prophylactic for preventing attacks of angina pectoris. The medication is prescribed for violations of the cochlear-vestibular nature of the ischemic nature associated with a disorder of the cerebral circulation. These include, in particular , Meniere's disease, tinnitus, auditory dysfunction. The tool "Trimetazidine" instructions for use recommends for chorioretinal vascular disorders, complicated by ischemia.

The recommended amount of medication per day is from forty to sixty milligrams. The drug is usually prescribed a day for two to three times twenty milligrams or 1-2 times thirty-five. Medication is taken with food.

Duration of treatment is established in accordance with the course of pathology and the patient's condition.

In clinical practice, while observing the dosing regimen and the recommendations of the specialist for taking medication, "Trimetazidine" did not register any overdoses.

The drug is not allowed to be taken with hypersensitivity.

Due to the lack of data on the effect of the drug "Trimetazidine" on the condition of the fetus, the pregnant woman or the newborn, the medication is not prescribed to patients during pregnancy and lactation.

The medication can trigger allergies, epigastric pain, itching, vomiting.

When appointing the drug "Trimetazidine" in renal failure, it is necessary to regularly monitor the functional activity of the kidneys. If necessary, the dosage should be reduced.

There was no evidence of the effects of the drug "Trimetazidine" on the ability to concentrate attention, drive a car and perform activities requiring high rates of mental and motor reactions.

It is not recommended to use the product after the expiration date stated on the package.

Before applying the medication "Trimetazidine", you should definitely study the annotation.